Which of these is NOT typically treated with monoclonal antibodies?

Monoclonal antibodies are highly specific proteins engineered to target particular antigens, making them effective in treating a variety of medical conditions. They are widely utilized in the treatment of certain autoimmune diseases, solid tumors, and even some infectious diseases. These therapies function by either marking cells for destruction by the immune system, blocking specific pathways, or neutralizing toxins.

Metabolic disorders, on the other hand, typically relate to abnormalities in chemical processes in the body and are not generally addressed with monoclonal antibodies. Treatment for metabolic disorders often involves dietary management, hormone replacement, or enzyme supplementation rather than targeted immune therapies. This is due to the fact that the underlying issues in metabolic disorders usually require different approaches that go beyond the action of monoclonal antibodies. Thus, it is accurate to state that metabolic disorders are not typically treated with these types of therapies.